A detailed history of Clarus Wealth Advisors transactions in Zoetis Inc. stock. As of the latest transaction made, Clarus Wealth Advisors holds 3,346 shares of ZTS stock, worth $587,791. This represents 0.33% of its overall portfolio holdings.

Number of Shares
3,346
Previous 3,583 6.61%
Holding current value
$587,791
Previous $621,000 5.15%
% of portfolio
0.33%
Previous 0.34%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$172.58 - $196.48 $40,901 - $46,565
-237 Reduced 6.61%
3,346 $653,000
Q2 2024

Jul 11, 2024

SELL
$145.54 - $178.83 $3,347 - $4,113
-23 Reduced 0.64%
3,583 $621,000
Q1 2024

Apr 11, 2024

BUY
$165.67 - $199.94 $115,968 - $139,958
700 Added 24.09%
3,606 $610,000
Q4 2023

Jan 22, 2024

BUY
$151.44 - $200.09 $2,877 - $3,801
19 Added 0.66%
2,906 $573,000
Q2 2023

Jul 10, 2023

BUY
$160.94 - $186.23 $36,211 - $41,901
225 Added 8.45%
2,887 $497,000
Q1 2023

Apr 10, 2023

BUY
$145.48 - $175.02 $387,267 - $465,903
2,662 New
2,662 $443,000
Q2 2022

Jul 13, 2022

BUY
$155.97 - $200.09 $53,497 - $68,630
343 Added 15.02%
2,627 $465,000
Q1 2022

Apr 12, 2022

BUY
$181.39 - $234.03 $414,294 - $534,524
2,284 New
2,284 $440,000
Q3 2019

Oct 11, 2019

SELL
$112.57 - $128.43 $5,628 - $6,421
-50 Closed
0 $0
Q2 2019

Jul 24, 2019

BUY
$97.98 - $114.28 $4,899 - $5,714
50 New
50 $6,000
Q1 2019

Apr 04, 2019

SELL
$81.56 - $100.67 $219,885 - $271,406
-2,696 Closed
0 $0
Q4 2018

Jan 07, 2019

BUY
$79.28 - $95.27 $213,738 - $256,847
2,696 New
2,696 $231,000
Q3 2018

Oct 03, 2018

SELL
$83.5 - $93.23 $1,002 - $1,118
-12 Closed
0 $0
Q2 2018

Jul 05, 2018

BUY
$79.9 - $89.2 $958 - $1,070
12 New
12 $1,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Clarus Wealth Advisors Portfolio

Follow Clarus Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Clarus Wealth Advisors with notifications on news.